Research Advances in Cellular-Level Fluorescence-Guided Imaging Technology for Surgery Treatment of Papillary Thyroid Microcarcinoma
10.3971/j.issn.1000-8578.2026.25.0549
- VernacularTitle:细胞级荧光导引成像技术在甲状腺微小乳头状癌手术治疗中的研究进展
- Author:
Ziyu CHEN
1
;
Hang SU
2
;
Fenghua ZHANG
2
Author Information
1. Department of Thyroid and Breast Surgery, Hebei General Hospital Affiliated to North China University of Science and Technology, Shijiazhuang 050051, China.
2. Department of Thyroid and Breast Surgery, Hebei General Hospital, Shijiazhuang 050051, China.
- Publication Type:SPECIALFEATURE
- Keywords:
Papillary thyroid microcarcinoma;
Cellular-level fluorescence-guided imaging technology;
Precision surgery;
Functional preservation
- From:
Cancer Research on Prevention and Treatment
2026;53(2):96-102
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of papillary thyroid microcarcinoma (PTMC) is steadily rising. Although conventional thyroid surgery techniques are well-established, they present challenges such as functional impairment and overtreatment. Cellular-level fluorescence-guided imaging technology (EndoSCell®) enables precise intraoperative tumor localization and real-time identification of neurovascular structures via high-resolution imaging and targeted labeling. This technology significantly improves surgical precision, reduces the incidence of postoperative complications including recurrent laryngeal nerve injury and hypoparathyroidism, and strengthens standards for functional preservation. This article aimed to systematically explore recent advances in the application of EndoSCell® for PTMC management, analyze its influence on the innovation of surgical approaches and the enhancement of functional preservation criteria, and discuss future directions, thereby providing a theoretical basis for clinical practice.
